PMC:7544934 / 1589-1788
Annnotations
LitCovid_Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T3 | 33-36 | https://glytoucan.org/Structures/Glycans/G00057MO | denotes | LDN |
| T4 | 33-36 | https://glytoucan.org/Structures/Glycans/G31736BK | denotes | LDN |
| T5 | 83-86 | https://glytoucan.org/Structures/Glycans/G00057MO | denotes | LDN |
| T6 | 83-86 | https://glytoucan.org/Structures/Glycans/G31736BK | denotes | LDN |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 38 | 68-72 | Gene | denotes | ACE2 | Gene:59272 |
| 54 | 164-185 | Disease | denotes | coronavirus infection | MESH:D018352 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T17 | 83-186 | Sentence | denotes | LDN may be considered as a target as the treatment and (or) adjuvant therapy for coronavirus infection. |